Clinical and Serological Features in Latin American IgG4-Related Disease Patients Differ According to Sex, Ethnicity, and Clinical Phenotype.

Lilith Stange Núñez, Vicente Juárez, Micaela Ana Cosatti, Nora María Aste, Carla Airoldi, Carolina Llanos, Cristian Fabián Vergara Melian, Daniel Erlij Opazo, Annelise Goecke, Paula Andrea Pastenes Montaño, Patricio Tate, Juan Pablo Pirola, Cecilia N Pisoni, Paula I Burgos, María Verónica Mezzano Robinson, Susana Michalland H, Francisco Silva Labra, Cristián Humberto Labarca Solar, María Verónica Lencina, Jorge Hernán Izquierdo Loaiza, David Julián Del Castillo Gil, Francisco Caeiro, Sergio Paira, Alejandra Herrera Moya, Diego Federico Baenas, María Carolina Cuellar Gutiérrez, Gabriela Hernández-Molina, Alberto Christian Ortiz, Oscar Neira, Miguel A Gutiérrez, Romina Calvo, Emanuel José Saad, Sergio Elgueta Pinochet, Jesica Gallo, Eduardo Martín-Nares, Bellanides Agustina Mansilla Aravena, María Elena Crespo Espíndola, Ernesto Cairoli, Ana María Bertoli, Mercedes Córdoba, Pamela Wurmann Kiblisky, Washington Javier Basualdo Arancibia, María Natalia Badilla Piñeiro, Carla Andrea Gobbi, Guillermo Ariel Berbotto

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2022;28(6):285-292

PMID: 35612589

Abstract

BACKGROUND/OBJECTIVE

Data on IgG4-related disease (IgG4-RD) come almost exclusively from cohorts from Asia, Europe, and North America. We conducted this study to describe the clinical presentation, phenotype distribution, and association with sex, ethnicity, and serological markers in a large cohort of Latin American patients with IgG4-RD.

METHODS

We performed a multicenter medical records review study including 184 Latin American IgG4-RD patients. We assigned patients to clinical phenotypes: group 1 (pancreato-hepato-biliary), group 2 (retroperitoneal/aortic), group 3 (head and neck-limited), group 4 (Mikulicz/systemic), and group 5 (undefined). We focused the analysis on how sex, ethnicity, and clinical phenotype may influence the clinical and serological presentation.

RESULTS

The mean age was 50.8 ± 15 years. Men and women were equally affected (52.2% vs 48.8%). Fifty-four patients (29.3%) were assigned to group 1, 21 (11.4%) to group 2, 57 (30.9%) to group 3, 32 (17.4%) to group 4, and 20 (10.8%) to group 5. Male sex was associated with biliary tract (odds ratio [OR], 3.4; 95% confidence interval [CI], 1.36-8.26), kidney (OR, 3.4; 95% CI, 1.28-9.25), and retroperitoneal involvement (OR, 5.3; 95% CI, 1.45-20). Amerindian patients presented more frequently with atopy history and gallbladder involvement. Group 3 had a female predominance.

CONCLUSIONS

Latin American patients with IgG4-RD were younger, and men and women were equally affected compared with White and Asian cohorts. They belonged more commonly to group 1 and group 3. Retroperitoneal and aortic involvement was infrequent. Clinical and serological features differed according to sex, ethnicity, and clinical phenotype.

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Address: From the Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, México.; Servicio de Reumatología, Hospital Privado Universitario de Córdoba, Córdoba, Argentina.; Servicio de Reumatología, Departamento de Medicina Interna, Hospital del Salvador, Santiago, Chile.; Sección de Reumatología, Hospital José María Cullen, Santa Fe, Argentina.; Departamento de Reumatologia, Hospital Naval Almirante Nef, Universidad de Valparaíso, Viña del Mar, Chile.; Departamento de Clínica Médica, Hospital Privado Universitario de Córdoba, Córdoba, Argentina.; Departamento de Medicina, Sección Reumatología, Hospital Clínico de la Universidad de Chile, Santiago, Chile.; Sección de Reumatología, Hospital Central de Reconquista, Reconquista, Santa Fe, Argentina.; Departamento de Inmunología Clínica y Reumatología, Pontificia Universidad Católica de Chile, Santiago.; Hospital Clínico Magallanes, Punta Arenas, Chile.; Hospital Señor del Milagro, Salta, Argentina.; Servicio de Reumatología, Clínica Universitaria Reina Fabiola, Universidad Católica de Córdoba, Córdoba, Argentina.; Sección Reumatología, Departamento de Medicina, Hospital Clínico Universidad de Chile, Santiago, Chile.; Sección Reumatología, Hospital del Salvador, Universidad de Chile.; Cátedra de Clínica Médica I, Hospital Córdoba, Facultad de Ciencias Médicas, UNC, Córdoba.; Servicio de Reumatología, Sanatorio Británico, Rosario.; Sección Reumatología e Inmunología, Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno," CABA, Buenos Aires.; Reumatología, Resistencia, Chaco.; Reumatología, Hospital Provincial, Rosario, Argentina.; Departamento de Medicina Oriente, Hospital del Salvador, Universidad de Chile.; Servicio de Reumatología, Departamento de Medicina, Hospital Clínico Universidad de Chile, Santiago.; Departamento de Reumatología, Servicio de Medicina, Hospital Carlos Van Buren, Valparaíso, Chile.; Organización Médica de Investigación, Buenos Aires.; Sanatorio Argentino, San Francisco, Córdoba, Argentina.; Centro de Artritis Reumatoide, Clínica Ciudad del Mar, Viña del Mar.; Clínica Las Condes, Hospital del Salvador.; Facultad de Medicina Clínica Alemana-Universidad del Desarrollo, Hospital Padre Hurtado, Santiago, Chile.; Grupo de Reumatología, Clínica de Occidente S.A., Cali, Colombia.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.